story of the week
Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone for Metastatic Nasopharyngeal Carcinoma After Induction Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial
JAMA Oncol 2022 Feb 17;[EPub Ahead of Print], GY Liu, WZ Li, DS Wang, H Liang, X Lv, YF Ye, C Zhao, LR Ke, SH Lv, N Lu, WX Bei, ZC Cai, X Chen, CX Liang, X Guo, WX Xia, YQ XiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.